Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nurix

Request full access

Develops small molecule inhibitors for the treatment of proliferative and degenerative diseases

Brisbane, United StatesFounded 2012Biotech & Life Sciences

About Nurix

Nurix Therapeutics is a biotechnology company focused on discovering and developing drugs that harness the natural process of protein degradation to treat a wide range of diseases. The company's core technology revolves around controlling ubiquitin E3 ligases, which are key enzymes responsible for protein breakdown in human cells. By targeting these enzymes, Nurix aims to develop novel therapeutic agents, particularly in the field of oncology, including small molecule immuno-oncology agents.

Nurix operates in the biopharmaceutical market, primarily serving patients with cancer and other serious diseases. The company employs a business model that involves drug discovery and development, with revenue generated through partnerships, licensing agreements, and potential future sales of its proprietary drugs.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2020

Nurix in the Brisbane ecosystem

Live from Dealroom

The Nurix office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series B and later6 investors entered at this stage

Employees mapped 377 incl. 4 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$31M

38 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Nurix on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.